Clinical trial
An Open-label, Randomized, Phase III Study Comparing Trifluridine/Tipiracil in Combination With Bevacizumab to Trifluridine/Tipiracil Monotherapy in Patients With Refractory Metastatic Colorectal Cancer (SUNLIGHT Study)
NCT04737187 is registered in ClinicalTrials.gov with Taiho Oncology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Randomized, Phase III Study Comparing Trifluridine/Tipiracil in Combination With Bevacizumab to Trifluridine/Tipiracil Monotherapy in Patients With Refractory Metastatic Colorectal Cancer (SUNLIGHT Study)
- Lead sponsor
- Taiho Oncology, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 25, 2020
- Completion date
- September 12, 2023
- Enrollment
- 492 (actual)
- Sites
- 99
Conditions
As the registry lists them; a condition with its own page is linked.
refractory metastatic colorectal cancer